logo
Plus   Neg
Share
Email

Airbus SE Q3 Adj. EBIT Declines - Quick Facts

Airbus SE (EADSF.PK,EADSY.PK) reported a third quarter net loss of 767 million euros compared to profit of 989 million euros, prior year. Loss per share was 0.98 euros compared to profit of 1.27 euros. Consolidated EBIT adjusted was 820 million euros, a decline of 49% year-on-year. The company said its third quarter EBIT adjusted mainly reflects lower commercial aircraft deliveries and lower activities in the space business.

Third quarter revenues were 11.21 billion euros, compared to 15.30 billion euros, last year. The company said its third revenues decreased by 27%, mainly driven by lower deliveries at Airbus and lower revenues at Airbus Defence and Space.

For the nine month period, EBIT adjusted was negative at 125 million euros compared to EBIT adjusted of 4.13 billion euros, last year. Consolidated revenues decreased to 30.2 billion euros from 46.2 billion euros.

The company targets at least breakeven free cash flow before M&A and customer financing in the fourth quarter of 2020.

"Despite the slower air travel recovery than anticipated, we converged commercial aircraft production and deliveries in the third quarter and we stopped cash consumption in line with our ambition," said Airbus CEO Guillaume Faury.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use. It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273. The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year.
Follow RTT